国际皮肤性病学杂志    2004 30 (6): 342-344   ISSN: 2096-5540  CN: 32-1880/R   雄激素源性脱发的治疗学进展 曾翰翔, 张宏 暨南大学附属第一医院皮肤科 广州 510632 收稿日期 2003-12-04  修回日期 null  网络版发布日期 null 参考文献  [1] Bayne EK, Flanagan J, Einstein M,et al. Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp. Br J Dermato1,1999,141:481-491. [2] Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol, 2002,12:38-49. [3] Lin JH, Chen WC. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study. Kaohsiung J Med Sci, 2002,8:379-335. [4] Tosti A, Piraccini BM, Soli M. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia. J Eur Acad Dermatol Venereol, 2001,15:418-421. [5] Price VH. Treatment of hair loss. N Engl J Med, 1999,341:964-973. [6] Sintov A, Serafimovich S, Gilhar A. New topical antiandrogenic formulations can stimulate hair growth in human bald scalp grafted onto mice. Int J Pharn, 2000, 194:125-134. [7] Vierhapper H, Maier H, Nowotny P,et al. Production rates of testosterone and of dihydrotestosterone in female pattern hair loss. Metabolism, 2003, 52:927-929. [8] Vexiau P, Chaspoux C, Boudou P,et al. Role of androgens in femalepattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch Dermatol Res, 2000, 292:598-604. [9] Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril, 2003,79:91-95. [10] Sovak M, Seligson AL, Kucerova R, et al. Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg, 2002,28:678-685. [11] Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol, 1996,35:465-469. [12] Hoffmann R,Niiyama S, Huth A, et al. 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol, 2002,11:376-380. [13] Otomo S. Hair growth effect of minoxidil. Nippon Yakurigaku Zasshi,2002,119:167-174. [14] Vexiau P,Chaspoux C, Boudou P,et al. Effects of minoxidil 2% vs.cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol, 2002,146:992-999. [15] Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical ninoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol,2002,47:377-385. [16] Unger WP, David LM. Laser hair transplantation. J Dermatol Surg Oncol. 1994,20:515-521. [17] Sadick NS, Shea CR, Nicholson J, et al. A comparative clinical and histologic study of hair transplantation using Er: YAG, Er: YAG/CO2,and standard punch techniques. Dermatol Surg, 2001,27:807-812. [18] Sadick N. Elliptografting: the right fit. Dernatol Surg, 2001,27:739-743. [19] Tsai RY, Lee SH, Chan HL,et al. The distribution of follicular units in the Chinese scalp: implications for reconstruction of natural-appearing hairlines in Orientals. Dermatol Surg, 2002,28:500-503. [20] Avram MR, Cole JP, Gandelman M, et al. The potential role of minoxidil in the hair transplantation setting. Dermatol Surg, 2002,28:894-900. [21] Lindenbaum ES, Feitelberg AL, Tendler M. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials. Dermatol Online J, 2003,9:4. [22] Lin L,Hoffman RM. Topical liposome delivery of molecules to hair follicles in mice. J Dermatol Sci, 1997,14:101-108. [23] Domashenko A, Gupta S, Cotsarelis G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol, 2000,18:420-423. 通讯作者: